Directed evolution of non-natural cytochrome P450 enzymes:Developing potent biocatalysts and tracing the determinants of enzyme functionality

非天然细胞色素 P450 酶的定向进化:开发有效的生物催化剂并追踪酶功能的决定因素

基本信息

项目摘要

Enzymes catalyze chemical reactions with exquisite selectivity and efficiency under mild conditions, making them superior tools for biotechnological applications and eco-friendly green chemistry. However, many industrially important chemical reactions are not catalyzed by any known enzyme, severely limiting the repertoire of chemical compounds accessible to biocatalytic production processes. To overcome this lack of useful enzymes, directed protein evolution has been applied to derive novel enzymes with non-natural catalytic activity. Recently, several novel cytochrome P450 enzymes catalyzing non-natural reactions were obtained with this approach, impressively demonstrating the versatility and evolvability of cytochrome P450 enzymes. However, the novel P450 enzymes frequently show low catalytic activity and low total turnover numbers due to fast enzyme inactivation. This low enzymatic activity prohibits their use as industrial biocatalysts and raises the fundamental question how novel, efficient enzymes develop in nature. I therefore propose to employ directed protein evolution to engineer non-natural cytochrome P450 enzymes catalyzing aziridination reactions towards high catalytic activity in live host cells. Libraries of P450 enzyme mutants will be generated by random mutagenesis and site-directed mutagenesis of selected enzyme residues. The resulting mutant libraries will be screened for P450 variants showing improved catalytic activity in whole live cells. Iterative rounds of mutagenesis and screening will be performed to evolve cytochrome P450 variants catalyzing aziridination reactions at high efficiency and stability in vivo. In a second step, these improved variants will be subjected to detailed biochemical and structural analyses to define the molecular determinants of in vivo enzymatic activity. The proposed research would thereby serve two objectives: First, novel cytochrome P450 enzymes with potent in vivo activity would be obtained, enabling their subsequent employment in biocatalytic production processes. Secondly, insights into the molecular determinants and structure-function relationships of enzyme catalytic activity in vivo will be generated, tracing the evolutionary paths leading from an inefficient enzyme to a highly active variant with potential relevance for engineering of other protein and enzyme families. Thus, the proposed research is expected to advance the field of biocatalysis and contribute to sustainable chemical production processes.
酶在温和条件下以精湛的选择性和效率催化化学反应,使其成为生物技术应用和环境友好的绿色化学的优质工具。然而,许多工业上重要的化学反应不是由任何已知的酶催化的,这严重限制了可用于生物催化生产过程的化合物库。为了克服有用酶的缺乏,定向蛋白质进化已被应用于衍生具有非天然催化活性的新型酶。最近,通过这种方法获得了几种催化非自然反应的新型细胞色素P450酶,令人印象深刻地证明了细胞色素P450酶的多功能性和可进化性。然而,由于酶失活速度快,新型 P450 酶经常表现出较低的催化活性和较低的总周转数。这种低酶活性阻碍了它们用作工业生物催化剂,并提出了如何在自然界中开发新型高效酶的基本问题。因此,我建议采用定向蛋白质进化来设计非天然细胞色素 P450 酶,催化氮丙啶化反应,从而在活宿主细胞中实现高催化活性。 P450酶突变体的文库将通过所选酶残基的随机诱变和定点诱变来产生。将筛选所得突变体文库中的 P450 变体,这些变体在整个活细胞中显示出改进的催化活性。将进行迭代诱变和筛选,以进化细胞色素 P450 变体,在体内高效且稳定地催化氮丙啶化反应。在第二步中,这些改进的变体将接受详细的生化和结构分析,以确定体内酶活性的分子决定因素。因此,拟议的研究将实现两个目标:首先,将获得具有有效体内活性的新型细胞色素 P450 酶,使其能够随后在生物催化生产过程中使用。其次,将深入了解体内酶催化活性的分子决定因素和结构功能关系,追踪从低效酶到高活性变体的进化路径,该变体与其他蛋白质和酶家族的工程具有潜在的相关性。因此,拟议的研究有望推动生物催化领域的发展,并为可持续的化学生产过程做出贡献。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dr. Oliver Brandenberg其他文献

Dr. Oliver Brandenberg的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

黄瓜花叶病毒复制酶与基因组末端非翻译区组合型协同进化的分子机制
  • 批准号:
    32370174
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于位点共进化网络协同调控羰基还原酶催化不对称还原的选择性和非天然底物活性及其分子机制
  • 批准号:
    22378168
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于人工进化策略的非P/A型R基因Pi-d2的适应性进化机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
原生动物四膜虫多交配型间自我/非自我识别机制的进化研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
半蒴苣苔属(苦苣苔科)对喀斯特和非喀斯特生境的适应性进化研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Engineering Receptors to Control Platelet Activation and Therapeutic Release
工程受体来控制血小板激活和治疗释放
  • 批准号:
    10607886
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Directed evolution of broadly fungible biosensors
广泛可替代生物传感器的定向进化
  • 批准号:
    10587024
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Potent broadly neutralizing antibody development against the HIV-1 fusion peptide epitope
针对 HIV-1 融合肽表位的强效广泛中和抗体的开发
  • 批准号:
    10838825
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Technologies for Directed Evolution of Glycoaptamers
糖适体定向进化技术
  • 批准号:
    10721663
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Engineering bacteria for production and delivery of the halogenated prodrug lead L-4-chlorokynurenine
用于生产和输送卤化前药先导 L-4-氯犬尿氨酸的工程细菌
  • 批准号:
    10607857
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了